105 related articles for article (PubMed ID: 35020252)
1. Poor treatment tolerance in head and neck cancer patients with low muscle mass.
Mascarella MA; Patel T; Vendra V; Gardiner L; Kergoat MJ; Kubik MW; Solari MG; Snyderman CH; Traylor KS; Ferris RL; Kim S; Duvvuri U; Sridharan SS
Head Neck; 2022 Apr; 44(4):844-850. PubMed ID: 35020252
[TBL] [Abstract][Full Text] [Related]
2. Cervical paraspinal skeletal muscle index outperforms frailty indices to predict postoperative adverse events in operable head and neck cancer with microvascular reconstruction.
Mascarella MA; Gardiner L; Patel T; Vendra V; Khan N; Kergoat MJ; Kubik MW; Solari MG; Snyderman CH; Traylor KS; Sridharan SS
Microsurgery; 2022 Mar; 42(3):209-216. PubMed ID: 34935198
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
[TBL] [Abstract][Full Text] [Related]
4. The impact of skeletal muscle depletion on older adult patients with head and neck cancer undergoing primary surgery.
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
J Geriatr Oncol; 2021 Jan; 12(1):128-133. PubMed ID: 32565144
[TBL] [Abstract][Full Text] [Related]
5. Low skeletal muscle mass as predictor of postoperative complications and decreased overall survival in locally advanced head and neck squamous cell carcinoma: the role of ultrasound of rectus femoris muscle.
Galli A; Colombo M; Carrara G; Lira Luce F; Paesano PL; Giordano L; Bondi S; Tulli M; Mirabile A; De Cobelli F; Bussi M
Eur Arch Otorhinolaryngol; 2020 Dec; 277(12):3489-3502. PubMed ID: 32535862
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
[TBL] [Abstract][Full Text] [Related]
7. Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma.
Roberti E; Merlano M; Ravanelli M; Alberti A; Esposito A; Gili R; Spinazzé S; Baré C; Jocollé G; Benasso M; Bertolotti F; Vecchio S; Bacigalupo A; Licitra L; Denaro N; Damico M; Lorini L; Gurizzan C; Alfieri S; Bossi P
Oral Oncol; 2023 Oct; 145():106540. PubMed ID: 37567147
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
[TBL] [Abstract][Full Text] [Related]
9. Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: An Indian tertiary care hospital experience.
Nagpal P; Pruthi DS; Pandey M; Yadav A; Singh H
Oral Oncol; 2021 Oct; 121():105483. PubMed ID: 34403887
[TBL] [Abstract][Full Text] [Related]
10. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer.
Wendrich AW; Swartz JE; Bril SI; Wegner I; de Graeff A; Smid EJ; de Bree R; Pothen AJ
Oral Oncol; 2017 Aug; 71():26-33. PubMed ID: 28688687
[TBL] [Abstract][Full Text] [Related]
11. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
[TBL] [Abstract][Full Text] [Related]
12. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
[TBL] [Abstract][Full Text] [Related]
14. Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer.
Fattouh M; Chang GY; Ow TJ; Shifteh K; Rosenblatt G; Patel VM; Smith RV; Prystowsky MB; Schlecht NF
Head Neck; 2019 Mar; 41(3):707-714. PubMed ID: 30582237
[TBL] [Abstract][Full Text] [Related]
15. Second-look PET-CT following an initial incomplete PET-CT response to (chemo)radiotherapy for head and neck squamous cell carcinoma.
Prestwich RJD; Arunsingh M; Zhong J; Dyker KE; Vaidyanathan S; Scarsbrook AF
Eur Radiol; 2020 Feb; 30(2):1212-1220. PubMed ID: 31485835
[TBL] [Abstract][Full Text] [Related]
16. Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.
Mroz EA; Patel KB; Rocco JW
Cancer; 2020 Jan; 126(9):1895-1904. PubMed ID: 32083741
[TBL] [Abstract][Full Text] [Related]
17. The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation.
Ganju RG; Morse R; Hoover A; TenNapel M; Lominska CE
Radiother Oncol; 2019 Aug; 137():117-124. PubMed ID: 31085391
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia results in poor survival rates in oral cavity cancer patients.
Lin SC; Lin YS; Kang BH; Yin CH; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; She YY; Liu YH; Lee CC
Clin Otolaryngol; 2020 May; 45(3):327-333. PubMed ID: 31769607
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of diffusion-weighted imaging and
Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed.
Zwart AT; Becker JN; Lamers MJ; Dierckx RAJO; de Bock GH; Halmos GB; van der Hoorn A
Eur Radiol; 2021 Jun; 31(6):4053-4062. PubMed ID: 33219847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
